Corey L - Search Results

1

Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.

Reeves DB, Huang Y, Duke ER, Mayer BT, Cardozo-Ojeda EF, Boshier FA, Swan DA, Rolland M, Robb ML, Mascola JR, Cohen MS, Corey L, Gilbert PB, Schiffer JT. Reeves DB, et al. Among authors: corey l. PLoS Comput Biol. 2020 Feb 21;16(2):e1007626. doi: 10.1371/journal.pcbi.1007626. eCollection 2020 Feb. PLoS Comput Biol. 2020. PMID: 32084132 Free PMC article.

2

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.

Gilbert PB, DeGruttola VG, Hudgens MG, Self SG, Hammer SM, Corey L. Gilbert PB, et al. Among authors: corey l. J Infect Dis. 2003 Jul 15;188(2):179-93. doi: 10.1086/376449. Epub 2003 Jul 1. J Infect Dis. 2003. PMID: 12854072

3

Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

Li F, Malhotra U, Gilbert PB, Hawkins NR, Duerr AC, McElrath JM, Corey L, Self SG. Li F, et al. Among authors: corey l. Vaccine. 2006 Nov 17;24(47-48):6893-904. doi: 10.1016/j.vaccine.2006.06.009. Epub 2006 Jun 27. Vaccine. 2006. PMID: 16890329

4

HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features.

Li F, Horton H, Gilbert PB, McElrath JM, Corey L, Self SG. Li F, et al. Among authors: corey l. Curr HIV Res. 2007 Jan;5(1):97-107. doi: 10.2174/157016207779316260. Curr HIV Res. 2007. PMID: 17266561

5

A framework for assessing immunological correlates of protection in vaccine trials.

Qin L, Gilbert PB, Corey L, McElrath MJ, Self SG. Qin L, et al. Among authors: corey l. J Infect Dis. 2007 Nov 1;196(9):1304-12. doi: 10.1086/522428. Epub 2007 Oct 2. J Infect Dis. 2007. PMID: 17922394

6

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN; Step Study Protocol Team. Buchbinder SP, et al. Among authors: corey l. Lancet. 2008 Nov 29;372(9653):1881-1893. doi: 10.1016/S0140-6736(08)61591-3. Epub 2008 Nov 13. Lancet. 2008. PMID: 19012954 Free PMC article. Clinical Trial.

7

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.

Schiffer JT, Kirby K, Sandmaier B, Storb R, Corey L, Boeckh M. Schiffer JT, et al. Among authors: corey l. Haematologica. 2009 Aug;94(8):1101-8. doi: 10.3324/haematol.2008.003186. Haematologica. 2009. PMID: 19644142 Free PMC article.

8

New concepts in understanding genital herpes.

Schiffer JT, Corey L. Schiffer JT, et al. Among authors: corey l. Curr Infect Dis Rep. 2009 Nov;11(6):457-64. doi: 10.1007/s11908-009-0066-7. Curr Infect Dis Rep. 2009. PMID: 19857385 Free PMC article.

9

Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.

Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Magaret A, Wald A, Corey L. Schiffer JT, et al. Among authors: corey l. Sci Transl Med. 2009 Nov 18;1(7):7ra16. doi: 10.1126/scitranslmed.3000193. Sci Transl Med. 2009. PMID: 20161655 Free PMC article.

10

Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.

Alsallaq RA, Schiffer JT, Longini IM Jr, Wald A, Corey L, Abu-Raddad LJ. Alsallaq RA, et al. Among authors: corey l. Sex Transm Dis. 2010 May;37(5):290-7. doi: 10.1097/OLQ.0b013e3181d3d023. Sex Transm Dis. 2010. PMID: 20351622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,077 results

Search Page